KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

Greenstone Biosciences accelerates drug discovery through human-relevant NAMs and advanced AI technologies. By combining scientific expertise with innovative platforms, we deliver safer, more effective therapies to patients in less time.

hiPSC-Derived Cells

Organoids

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

Tag Post :

Share This :

Featured Publication

Have Questions?

Quick Links

Services

Contact Us

hiPSC-Derived Cells

Organoids

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

Tag Post :

Share This :

Featured Publication

3D Biomechanics and Epigenomics Reveal Atypical Fibroblast Responses in Cardiometabolic Disease

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

Single-cell ionic current phenotyping elucidates noncanonical features and predictive potential of cardiomyocytes during automated drug experiments

Have Questions?

Quick Links

Services

Contact Us